BICO Group AB
OTC:CLLKF

Watchlist Manager
BICO Group AB Logo
BICO Group AB
OTC:CLLKF
Watchlist
Price: 1.98 USD -1% Market Closed
Market Cap: $136.8m

Net Margin

-45.3%
Current
Improving
by 2.3%
vs 3-y average of -47.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-45.3%
=
Net Income
kr-683m
/
Revenue
kr1.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-45.3%
=
Net Income
$-683m
/
Revenue
kr1.5B

Peer Comparison

Country Company Market Cap Net
Margin
SE
BICO Group AB
STO:BICO
1.2B SEK
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
218.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.8B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.1B CNY
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
39.3B USD
Loading...
US
Agilent Technologies Inc
NYSE:A
37.8B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
US
Illumina Inc
NASDAQ:ILMN
22.2B USD
Loading...

Market Distribution

Lower than 80% of companies in Sweden
Percentile
20th
Based on 2 084 companies
20th percentile
-45.3%
Low
-5 565 412.8% — -5.3%
Typical Range
-5.3% — 7.5%
High
7.5% — 12 228%
Distribution Statistics
Sweden
Min -5 565 412.8%
30th Percentile -5.3%
Median 3%
70th Percentile 7.5%
Max 12 228%

BICO Group AB
Glance View

BICO Group AB is a bioconvergence company, which engages in the provision of technologies, products, and services to create, understand and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 890 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

CLLKF Intrinsic Value
4.5 USD
Undervaluation 56%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-45.3%
=
Net Income
kr-683m
/
Revenue
kr1.5B
What is BICO Group AB's current Net Margin?

The current Net Margin for BICO Group AB is -45.3%, which is above its 3-year median of -47.6%.

How has Net Margin changed over time?

Over the last 3 years, BICO Group AB’s Net Margin has decreased from 2% to -45.3%. During this period, it reached a low of -86.2% on Sep 30, 2023 and a high of 2% on Sep 30, 2022.

Back to Top